Autori: Hajek Roman
| Naslov | Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy (Meeting Abstract) |
| Autori | Mateos Maria-Victoria Szarejko Monika Bila Jelena S  Schjesvold Fredrik Spicka Ivan Maisnar Vladimir Jurczyszyn Artur Grudeva-Popova Zhanet Hajek Roman Usenko Hanna Thuresson Marcus Norin Stefan Jarefors Sara Richardson Paul Pour Ludek
|
| Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S200-S201 |
| Ispravka | Web of Science Elečas Rang časopisa |
     |
| Naslov | OPTIMUM Trial: Randomized Comparison of Thalidomide Versus Dexamethasone for Relapsed Myeloma (Meeting Abstract) |
| Autori | Kropff M Baylon H Spicka Ivan Hillengass J Roback T Salwender H Hajek Roman Liebisch P Boskovic Darinka V Goranov S Zerbib R |
| Info | CLINICAL LYMPHOMA & MYELOMA, (2009), vol. 9 br. , Suppl. Suppl. 1, str. S64-S64 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
